Retatrutide is an investigational triple receptor agonist that targets GLP-1, GIP, and glucagon receptors for weight management and metabolic health. Learn how it works, the latest research, and why it is not yet approved in Malaysia.

Discover how GLP-1 and GIP hormones are transforming medical weight management. Learn how treatments such as semaglutide and tirzepatide help regulate appetite, blood sugar, and metabolism to support healthier, sustainable weight loss under medical supervision.